nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.00603	0.415	CrCbGaD
Doxylamine—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.00372	0.257	CrCbGaD
Doxylamine—Toremifene—ABCB1—peripheral nervous system neoplasm	0.0017	0.117	CrCbGaD
Doxylamine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00138	0.0014	CcSEcCtD
Doxylamine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00138	0.0014	CcSEcCtD
Doxylamine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00138	0.0014	CcSEcCtD
Doxylamine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Doxylamine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Doxylamine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Doxylamine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Doxylamine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Doxylamine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Doxylamine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.00138	CcSEcCtD
Doxylamine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00135	0.00137	CcSEcCtD
Doxylamine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00135	0.00137	CcSEcCtD
Doxylamine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00135	0.00137	CcSEcCtD
Doxylamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00134	0.00135	CcSEcCtD
Doxylamine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00133	0.00135	CcSEcCtD
Doxylamine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00135	CcSEcCtD
Doxylamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00134	CcSEcCtD
Doxylamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00134	CcSEcCtD
Doxylamine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00132	0.00134	CcSEcCtD
Doxylamine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00133	CcSEcCtD
Doxylamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00131	0.00133	CcSEcCtD
Doxylamine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00133	CcSEcCtD
Doxylamine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00132	CcSEcCtD
Doxylamine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0013	0.00132	CcSEcCtD
Doxylamine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.0013	0.00132	CcSEcCtD
Doxylamine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00132	CcSEcCtD
Doxylamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00129	0.00131	CcSEcCtD
Doxylamine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00131	CcSEcCtD
Doxylamine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.00129	0.0013	CcSEcCtD
Doxylamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00128	0.0013	CcSEcCtD
Doxylamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.0013	CcSEcCtD
Doxylamine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00128	0.0013	CcSEcCtD
Doxylamine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00129	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00129	CcSEcCtD
Doxylamine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00127	0.00128	CcSEcCtD
Doxylamine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00128	CcSEcCtD
Doxylamine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00126	0.00128	CcSEcCtD
Doxylamine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00126	0.00127	CcSEcCtD
Doxylamine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00127	CcSEcCtD
Doxylamine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00127	CcSEcCtD
Doxylamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Doxylamine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Doxylamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00123	0.00125	CcSEcCtD
Doxylamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00123	0.00125	CcSEcCtD
Doxylamine—Rash—Topotecan—peripheral nervous system neoplasm	0.00123	0.00125	CcSEcCtD
Doxylamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00123	0.00125	CcSEcCtD
Doxylamine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00123	0.00125	CcSEcCtD
Doxylamine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00124	CcSEcCtD
Doxylamine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Doxylamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Doxylamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Doxylamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Doxylamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Doxylamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Doxylamine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00122	0.00124	CcSEcCtD
Doxylamine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00122	0.00123	CcSEcCtD
Doxylamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Doxylamine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Doxylamine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Doxylamine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Doxylamine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Doxylamine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00123	CcSEcCtD
Doxylamine—Rash—Melphalan—peripheral nervous system neoplasm	0.0012	0.00122	CcSEcCtD
Doxylamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0012	0.00122	CcSEcCtD
Doxylamine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Doxylamine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Doxylamine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Doxylamine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00118	0.0012	CcSEcCtD
Doxylamine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00118	0.0012	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00119	CcSEcCtD
Doxylamine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00119	CcSEcCtD
Doxylamine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00119	CcSEcCtD
Doxylamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Doxylamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Doxylamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00116	0.00118	CcSEcCtD
Doxylamine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00115	0.00117	CcSEcCtD
Doxylamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00117	CcSEcCtD
Doxylamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00117	CcSEcCtD
Doxylamine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00115	0.00116	CcSEcCtD
Doxylamine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00116	CcSEcCtD
Doxylamine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00114	0.00115	CcSEcCtD
Doxylamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00113	0.00115	CcSEcCtD
Doxylamine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Doxylamine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Doxylamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00112	0.00113	CcSEcCtD
Doxylamine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00113	CcSEcCtD
Doxylamine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Doxylamine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00112	CcSEcCtD
Doxylamine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00112	CcSEcCtD
Doxylamine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Doxylamine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.0011	CcSEcCtD
Doxylamine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00109	0.0011	CcSEcCtD
Doxylamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Doxylamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Doxylamine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00109	CcSEcCtD
Doxylamine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00109	CcSEcCtD
Doxylamine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00107	0.00109	CcSEcCtD
Doxylamine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00107	CcSEcCtD
Doxylamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00104	0.00106	CcSEcCtD
Doxylamine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Doxylamine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00105	CcSEcCtD
Doxylamine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Doxylamine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Doxylamine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00102	0.00103	CcSEcCtD
Doxylamine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00101	0.00103	CcSEcCtD
Doxylamine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Doxylamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Doxylamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00102	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000998	0.00101	CcSEcCtD
Doxylamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000998	0.00101	CcSEcCtD
Doxylamine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000995	0.00101	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000992	0.00101	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000989	0.001	CcSEcCtD
Doxylamine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000987	0.001	CcSEcCtD
Doxylamine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000979	0.000994	CcSEcCtD
Doxylamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00097	0.000984	CcSEcCtD
Doxylamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000967	0.000981	CcSEcCtD
Doxylamine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000965	0.000979	CcSEcCtD
Doxylamine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000944	0.000958	CcSEcCtD
Doxylamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00094	0.000954	CcSEcCtD
Doxylamine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000939	0.000953	CcSEcCtD
Doxylamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000935	0.000949	CcSEcCtD
Doxylamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000933	0.000946	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000931	0.000945	CcSEcCtD
Doxylamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000925	0.000939	CcSEcCtD
Doxylamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000924	0.000938	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000923	0.000937	CcSEcCtD
Doxylamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000921	0.000934	CcSEcCtD
Doxylamine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00092	0.000933	CcSEcCtD
Doxylamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00091	0.000923	CcSEcCtD
Doxylamine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000903	0.000917	CcSEcCtD
Doxylamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000899	0.000912	CcSEcCtD
Doxylamine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000897	0.00091	CcSEcCtD
Doxylamine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000893	0.000906	CcSEcCtD
Doxylamine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000892	0.000905	CcSEcCtD
Doxylamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000891	0.000904	CcSEcCtD
Doxylamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00089	0.000904	CcSEcCtD
Doxylamine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000886	0.000899	CcSEcCtD
Doxylamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000871	0.000884	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000869	0.000882	CcSEcCtD
Doxylamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000855	0.000868	CcSEcCtD
Doxylamine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000854	0.000867	CcSEcCtD
Doxylamine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000851	0.000864	CcSEcCtD
Doxylamine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000844	0.000857	CcSEcCtD
Doxylamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000844	0.000856	CcSEcCtD
Doxylamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00084	0.000852	CcSEcCtD
Doxylamine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000838	0.000851	CcSEcCtD
Doxylamine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000838	0.000851	CcSEcCtD
Doxylamine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000836	0.000848	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000826	0.000838	CcSEcCtD
Doxylamine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000822	0.000834	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000819	0.000832	CcSEcCtD
Doxylamine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000816	0.000828	CcSEcCtD
Doxylamine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000814	0.000826	CcSEcCtD
Doxylamine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00081	0.000822	CcSEcCtD
Doxylamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000795	0.000806	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00079	0.000802	CcSEcCtD
Doxylamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000788	0.0008	CcSEcCtD
Doxylamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000787	0.000799	CcSEcCtD
Doxylamine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000786	0.000798	CcSEcCtD
Doxylamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000783	0.000795	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000781	0.000793	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000776	0.000787	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000776	0.000787	CcSEcCtD
Doxylamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000757	0.000768	CcSEcCtD
Doxylamine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000756	0.000767	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000755	0.000766	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.000765	CcSEcCtD
Doxylamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000742	0.000753	CcSEcCtD
Doxylamine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00073	0.00074	CcSEcCtD
Doxylamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000728	0.000739	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.000738	CcSEcCtD
Doxylamine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000723	0.000733	CcSEcCtD
Doxylamine—Rash—Etoposide—peripheral nervous system neoplasm	0.000722	0.000733	CcSEcCtD
Doxylamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000721	0.000732	CcSEcCtD
Doxylamine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000709	0.00072	CcSEcCtD
Doxylamine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000707	0.000717	CcSEcCtD
Doxylamine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000704	0.000714	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.00071	CcSEcCtD
Doxylamine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000695	0.000705	CcSEcCtD
Doxylamine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000681	0.000691	CcSEcCtD
Doxylamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00068	0.00069	CcSEcCtD
Doxylamine—Tamoxifen—ABCB1—peripheral nervous system neoplasm	0.000677	0.0466	CrCbGaD
Doxylamine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.000685	CcSEcCtD
Doxylamine—Doxepin—ABCB1—peripheral nervous system neoplasm	0.000675	0.0465	CrCbGaD
Doxylamine—Methadone—ABCB1—peripheral nervous system neoplasm	0.000671	0.0462	CrCbGaD
Doxylamine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000679	CcSEcCtD
Doxylamine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000667	0.000677	CcSEcCtD
Doxylamine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000662	0.000671	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000656	0.000666	CcSEcCtD
Doxylamine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000655	0.000664	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.000663	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000651	0.000661	CcSEcCtD
Doxylamine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000647	0.000657	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000643	0.000653	CcSEcCtD
Doxylamine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000642	0.000651	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.00064	CcSEcCtD
Doxylamine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000639	CcSEcCtD
Doxylamine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000628	0.000638	CcSEcCtD
Doxylamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000626	0.000636	CcSEcCtD
Doxylamine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000621	0.00063	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000617	0.000626	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000612	0.000621	CcSEcCtD
Doxylamine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000612	0.000621	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000606	0.000615	CcSEcCtD
Doxylamine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.0006	0.000609	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000599	0.000608	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000603	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000591	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.00059	CcSEcCtD
Doxylamine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000581	0.000589	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.000588	CcSEcCtD
Doxylamine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.000583	CcSEcCtD
Doxylamine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000572	0.000581	CcSEcCtD
Doxylamine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000571	0.000579	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.000574	CcSEcCtD
Doxylamine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000566	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.000563	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000562	CcSEcCtD
Doxylamine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000553	0.000562	CcSEcCtD
Doxylamine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000549	0.000557	CcSEcCtD
Doxylamine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000545	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000537	CcSEcCtD
Doxylamine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000537	CcSEcCtD
Doxylamine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.000536	CcSEcCtD
Doxylamine—Imipramine—ABCB1—peripheral nervous system neoplasm	0.000525	0.0362	CrCbGaD
Doxylamine—Amitriptyline—ABCB1—peripheral nervous system neoplasm	0.000522	0.036	CrCbGaD
Doxylamine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000524	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.00052	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.00052	CcSEcCtD
Doxylamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00051	0.000517	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000515	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000497	CcSEcCtD
Doxylamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000473	0.00048	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000479	CcSEcCtD
Doxylamine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000467	CcSEcCtD
Doxylamine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000461	CcSEcCtD
Doxylamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000446	CcSEcCtD
Doxylamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000444	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000432	CcSEcCtD
Doxylamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000431	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000426	CcSEcCtD
Doxylamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000414	CcSEcCtD
Doxylamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000412	CcSEcCtD
Doxylamine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000411	CcSEcCtD
Doxylamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000404	0.00041	CcSEcCtD
Doxylamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000399	CcSEcCtD
Doxylamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000387	CcSEcCtD
Doxylamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000383	CcSEcCtD
Doxylamine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.00038	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.00038	CcSEcCtD
Doxylamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000358	CcSEcCtD
